Integrin beta 4/CD104 Antibody (UM-A9), Novus Biologicals™

Integrin beta 4/CD104

Western Blot 0.5-1ug/ml, Flow Cytometry 0.5-1ug/million cells, Immunocytochemistry/Immunofluorescence 0.5-1ug/ml, Immunoprecipitation 0.5-1ug/500ug protein lysate, SDS-Page

Monoclonal

Purified

RUO

Human

P16144

3691

Human squamous cell carcinoma (UM-SCC1)

Primary

Store at 4C.

205 kDa

UM-A9

Western Blot, Flow Cytometry, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, SDS-Page

Unconjugated

Mouse

Adaptive Immunity, Immunology, Phospho Specific, Signal Transduction

PBS with 0.05% BSA. with 0.05% Sodium Azide

CD104, CD104 antigen, GP150, integrin beta-4, integrin beta-4 subunit, integrin, beta 4

ITGB4

IgG2a κ

Protein A purified

Recognizes a protein of 205kDa, which is identified as integrin beta-4 (ITGB4). Its epitope is localized in the extracellular domain of ITGB4 protein. Integrins are heterodimers comprised of alpha and beta subunits, that are non-covalently associated transmembrane glycoprotein receptors. Different combinations of alpha and beta polypeptides form complexes that vary in their ligand-binding specificities. Integrins mediate cell-matrix or cell-cell adhesion, and transduced signals that regulate gene expression and cell growth. This gene encodes the integrin beta-4 subunit, a receptor for the laminins. This subunit tends to associate with alpha-6 subunit and is likely to play a pivotal role in the biology of invasive carcinoma. Mutations in this gene are associated with epidermolysis bullosa with pyloric atresia. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.